The recently published Cass Review found that 'gender medicine' is 'built on shaky foundations' and recommended against surgical or pharmaceutical intervention for gender-confused children.
The company is engaging in talks “to determine whether they can deliver an actionable, binding proposal that provides superior value and certainty for WBD shareholders through their best and final off...